NGT3’s CEO on boosting Jewish-Arab collaboration, portfolio mix and more
Zohar Gendler, managing partner and CEO, NGT3
Nazareth, Israel-based NGT3 is an early-stage investment firm that focuses on the life sciences, medical devices and pharmaceutical companies working on next-generation technologies. The firm began two decades ago as an incubator and floated its first venture capital fund in 2013. It is now doing the groundwork for the second […]
To read the rest of this article, you must be a subscriber. Click here to buy a subscription plan or Login here if you are already a subscriber.
